For decades, glaucoma treatment has relied heavily on topical medications—often leading to daily eye drops, side effects, and ongoing frustration. At VOLD Vision, we take a different approach. Led by a globally recognized pioneer in glaucoma innovation, our focus is to help patients preserve their sight without relying on lifelong eye drops through the latest advancements in minimally invasive glaucoma surgery (MIGS).

What Is Minimally Invasive Glaucoma Surgery (MIGS)?

MIGS refers to a new generation of surgical techniques designed to reduce eye pressure in glaucoma patients with far less trauma, faster recovery, and fewer risks than traditional surgery. These procedures often involve microscopic stents, laser-based therapies, or micro-incisional devices that improve fluid outflow—effectively lowering intraocular pressure (IOP) and protecting vision.

Why Choose MIGS Over Traditional Glaucoma Treatment?

• Freedom from Drops: Our goal is simple—help you reduce or eliminate the need for daily glaucoma medications.

• Quick Recovery: MIGS procedures are typically outpatient with minimal downtime.

• Fewer Side Effects: No preservatives, no medication fatigue, no long-term toxicity.

• Can Be Combined with Cataract Surgery: Many patients can have both addressed in a single, elegant procedure.

• Precision-Driven: Performed using cutting-edge imaging and surgical tools, including the technologies pioneered right here at VOLD Vision.

A Surgeon Who’s Shaped the Future of Glaucoma Care

Dr. Steven Vold, founder of VOLD Vision, is not only a leading glaucoma specialist—he is a true innovator. As the first surgeon in the U.S. to perform many MIGS procedures and a holder of multiple patents in this field, Dr. Vold has helped develop and advance the very technologies now being used around the world. He has trained physicians across the U.S. and internationally and continues to lead the field in surgical excellence and innovation.

When you choose VOLD Vision, you’re not just choosing a surgeon—you’re choosing one of the global thought leaders in modern glaucoma care.

Who Is a Candidate for MIGS?

• Patients diagnosed with mild to moderate open-angle glaucoma

• Those experiencing side effects or frustration from eye drop use

• Cataract patients with coexisting glaucoma

• Individuals seeking a less invasive alternative to traditional glaucoma surgery

Experience Personalized, Proven Glaucoma Relief

At VOLD Vision, we combine breakthrough technology with world-renowned expertise to offer solutions that prioritize your long-term health, comfort, and independence. If you’re tired of drops—or want to proactively protect your sight—MIGS may be the ideal solution.

Schedule your consultation today and discover how minimally invasive glaucoma surgery can change your life.

VOLD Vision — Your Sight is Our Vision.